Legend Biotech Corporation (FRA:9LB)

Germany · Delayed Price · Currency is EUR

15.20

-0.20 (-1.30%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biotechnology	627.24M	285.14M	117.01M	68.83M	75.00M
Biotechnology Growth	119.97%	143.70%	70.00%	-8.23%	11.21%
Total	627.24M	285.14M	117.01M	68.83M	75.00M
Total Growth	119.97%	143.70%	70.00%	-8.23%	11.21%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States of America	579.05M	269.89M	116.60M	65.40M	75.00M
United States of America Growth	114.55%	131.47%	78.29%	-12.80%	25.05%
China	320.00K	179.00K	328.00K	3.42M	-
China Growth	78.77%	-45.43%	-90.42%	-	-
Europe	47.87M	15.07M	75.00K	-	-
Europe Growth	217.66%	19993.33%	-	-	-
Total	627.24M	285.14M	117.01M	68.83M	75.00M
Total Growth	119.97%	143.70%	70.00%	-8.23%	25.04%

Source: S&P Global Market Intelligence.